SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000810509-15-000008
Filing Date
2015-08-10
Accepted
2015-08-10 16:30:54
Documents
13
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q navb0630201510q.htm 10-Q 823997
2 EXHIBIT 10.1 navb06302015ex10-1.htm EX-10.1 78564
3 EXHIBIT 10.2 navb06302015ex10-2.htm EX-10.2 78544
4 EXHIBIT 31.1 navb06302015ex31-1.htm EX-31.1 9879
5 EXHIBIT 31.2 navb06302015ex31-2.htm EX-31.2 9875
6 EXHIBIT 32.1 navb06302015ex32-1.htm EX-32.1 5126
7 EXHIBIT 32.2 navb06302015ex32-2.htm EX-32.2 5180
  Complete submission text file 0000810509-15-000008.txt   4986189

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT navb-20150630.xml EX-101.INS 758837
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT navb-20150630.xsd EX-101.SCH 41489
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT navb-20150630_cal.xml EX-101.CAL 61678
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT navb-20150630_def.xml EX-101.DEF 215010
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT navb-20150630_lab.xml EX-101.LAB 608119
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT navb-20150630_pre.xml EX-101.PRE 346061
Mailing Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017
Business Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35076 | Film No.: 151041133
SIC: 2835 In Vitro & In Vivo Diagnostic Substances